Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 12/20 | 0.34 |
| ▸ | PDE1A | P54750 | 3/20 | 0.32 |
| ▸ | PDE1B | Q01064 | 3/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.32 |
| ▸ | PDE1C | Q14123 | 3/20 | 0.32 |
| ▸ | PDE6A | P16499 | 1/20 | 0.32 |
| ▸ | PDE6B | P35913 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30890782 | 0.80 | PDE1A (0.33) | OTUD7BPDE1APDE1BPDE4DPDE1C | |
| SCHEMBL30890438 | 0.79 | IMPDH2 (0.34) | OTUD7B | |
| SCHEMBL30890618 | 0.76 | F2 (0.34) | OTUD7B | |
| SCHEMBL22695464 | 0.71 | OTUD7B (0.44) | OTUD7B | |
| SCHEMBL30890602 | 0.71 | CNR2 (0.32) | — | |
| SCHEMBL30890807 | 0.71 | CNR2 (0.32) | — | |
| SCHEMBL30992248 | 0.70 | IMPDH2 (0.43) | OTUD7BPOLB | |
| SCHEMBL24307027 | 0.69 | OTUD7B (0.42) | OTUD7B | |
| SCHEMBL24306294 | 0.68 | OTUD7B (0.34) | OTUD7B | |
| SCHEMBL30890780 | 0.64 | MAOB (0.34) | MAOAMAOBTSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |